In the field of molecular biology detection, real-time fluorescence quantitative polymerase chain reaction amplification instrument has become a core tool for scientific research and clinical diagnosis due to its performance. Compared to traditional PCR technology, qPCR amplifiers have achieved a leapfrog development in detection technology through real-time fluorescence monitoring and precise quantification capabilities, playing an irreplaceable role in epidemic prevention and control, disease diagnosis, food safety, and other fields.
High sensitivity and specificity are the core technical advantages of qPCR amplifiers. Its detection limit can be as low as 0.1 to 5 μ g of nucleic acid samples, which can accurately capture trace amounts of pathogens or gene fragments. In the sterile rapid testing protocol recommended by the Chinese Pharmacopoeia in 2025, Thermo Fisher Scientific's SteriSEQ ™ The reagent kit relies on qPCR technology to detect bacteria and fungi with 5-25 genome copies, ensuring drug safety.
The efficient and rapid detection capability makes qPCR amplifiers shine in emergency scenarios. Traditional PCR detection often takes several hours, while qPCR technology significantly shortens the detection time by optimizing the reaction system and program. Thermo Fisher's sterile rapid testing solution compresses the testing time to within 5 hours, which is nearly 70 times more efficient than the traditional 14 day sterile culture method. During the COVID-19, rapid qPCR detection bought valuable time for virus screening and epidemic prevention and control. Dusseldorf Hospital used direct qPCR technology without RNA extraction to efficiently complete high-frequency screening of medical staff.
The flexible and diverse detection modes have expanded the application boundaries of qPCR amplifiers. The integration of melting curve analysis technology enables qPCR to achieve a breakthrough from single to multiple detection. The study reported in the BMCVeterinary Research journal in 2025 successfully detected three viruses in pigs simultaneously using SYBRGreenI dye combined with melting curves, with a detection limit of 1.87 × 10 ² copies/μ L and sensitivity far exceeding traditional PCR. The more advanced MeltArray technology can detect up to 62 targets in a single reaction through two-dimensional labels of fluorescent color and Tm value, providing powerful tools for pathogen typing and genetic variation analysis.
In terms of cost control and compliance, qPCR amplifiers have also demonstrated significant advantages. With the breakthrough of domestic technology, the price of mid-range qPCR instruments has dropped to the range of 10000 to 50000 yuan, and the manufacturing cost has been further reduced by 15% to 20% due to the localization of core components. At the same time, qPCR technology conforms to the MIQE (Minimum Information Fluorescent Quantitative PCR Experiment) standard and the pharmacopoeia standards of various countries, and its compliant application in clinical diagnosis, biopharmaceuticals and other fields has been widely recognized, promoting its popularization in precision medical scenarios such as early screening of tumors and genetic disease diagnosis.
From the prevention and control of the COVID-19 to routine disease diagnosis, from scientific research laboratories to industrial production quality control, the qPCR amplification instrument, with its high sensitivity, rapidity, flexibility and compliance, continues to promote the innovation of molecular diagnostic technology and provide solid technical support for human health and life science research.